Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aucubuside
1. 479-98-1
2. Aucuboside
3. Rhinanthin
4. 2g52gs8uml
5. Rhimantin
6. Chebi:69796
7. (1s,4ar,5s,7as)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl Beta-d-glucopyranoside
8. Einecs 207-540-8
9. Unii-2g52gs8uml
10. Nsc 407293
11. Nsc-407293
12. (2s,3r,4s,5s,6r)-2-[[(1s,4ar,5s,7as)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
13. Mfcd00136026
14. Aucubin [mi]
15. Aucubin, Analytical Standard
16. 1,4a,5,7a-tetrahydro-5-hydroxy-7-hydroxymethylcyclopenta(c)pyran-1-yl-beta-d-glucopyranoside
17. Mls002473252
18. Schembl381032
19. Chembl514882
20. Megxp0_001729
21. Acon1_002452
22. Dtxsid60963965
23. Hms3098b08
24. Hy-n0664
25. Zinc4098334
26. S5459
27. Akos015896774
28. Ccg-267985
29. Cs-5367
30. Lmpr0102070006
31. Ncgc00169833-01
32. Ncgc00169833-02
33. (1s-(1alpha,4aalpha,5alpha,7aalpha))-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta(c)pyran-1-yl-beta-d-glucopyranoside
34. (2s,3r,4s,5s,6r)-2-(((1s,4ar,5s,7as)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
35. (2s,3r,4s,5s,6r)-2-[[(1s,4ar,5s,7as)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
36. Ac-33938
37. As-74899
38. Smr001397339
39. N2758
40. C09771
41. 479a981
42. A827419
43. Aucubin, Primary Pharmaceutical Reference Standard
44. Q418014
45. Aucubin (constituent Of Chaste Tree) [dsc]
46. Q-100516
47. (1s,4ar,5s,7as)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta(c)pyran-1-yl-.beta.-d-glucopyranoside
48. (2s,3r,4s,5s,6r)-2-((1s,4ar,5r,7as)-5-hydroxy-7-hydroxymethyl-1,4a,5,7a-tetrahydro-cyclopenta[c]pyran-1-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
49. (2s,3r,4s,5s,6r)-2-((1s,4ar,5s,7as)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
50. (2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,7as)-5-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
51. .beta.-d-glucopyranoside, (1s,4ar,5s,7as)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl
52. B-d-glucopyranoside, (1s,4ar,5s,7as)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl
| Molecular Weight | 346.33 g/mol |
|---|---|
| Molecular Formula | C15H22O9 |
| XLogP3 | -3 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 346.12638228 g/mol |
| Monoisotopic Mass | 346.12638228 g/mol |
| Topological Polar Surface Area | 149 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 507 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Aucubin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aucubin manufacturer or Aucubin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aucubin manufacturer or Aucubin supplier.
PharmaCompass also assists you with knowing the Aucubin API Price utilized in the formulation of products. Aucubin API Price is not always fixed or binding as the Aucubin Price is obtained through a variety of data sources. The Aucubin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aucubin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aucubin, including repackagers and relabelers. The FDA regulates Aucubin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aucubin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aucubin supplier is an individual or a company that provides Aucubin active pharmaceutical ingredient (API) or Aucubin finished formulations upon request. The Aucubin suppliers may include Aucubin API manufacturers, exporters, distributors and traders.
Aucubin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aucubin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aucubin GMP manufacturer or Aucubin GMP API supplier for your needs.
A Aucubin CoA (Certificate of Analysis) is a formal document that attests to Aucubin's compliance with Aucubin specifications and serves as a tool for batch-level quality control.
Aucubin CoA mostly includes findings from lab analyses of a specific batch. For each Aucubin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aucubin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aucubin EP), Aucubin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aucubin USP).
